BOSTON--(BUSINESS WIRE)--
PureTech Health plc ("PureTech", LSE: PRTC), an advanced, clinical-stage biopharmaceutical company, today announced that Bharatt Chowrira, President and Chief of Business and Strategy at PureTech Health, will present at the Jefferies 2017 Global Healthcare Conference in New York City on Thursday, June 8, at 9:30am EDT. A webcast of the presentation will be available at http://puretechhealth.com/investors.php under the Reports and Presentations tab.
Additionally, Jonathan Freeman, Chief Business Officer of Vedanta Biosciences, will present on Wednesday, June 7, at 9:30am EDT. Vedanta Biosciences is a PureTech Health subsidiary pioneering the development of a novel class of therapies designed to modulate pathways of interaction between the human microbiome and the host immune system.
About PureTech Health
PureTech Health (PureTech Health plc,
PRTC.L) is an advanced, clinical-stage biopharmaceutical company
developing novel medicines targeting serious diseases that result from
dysfunctions in the immune, nervous, and gastro-intestinal systems by
intervening early and addressing the underlying pathophysiology of
disease. The Company is advancing a rich pipeline that includes two
pivotal or registration studies expected to read out in 2017, multiple
human proof-of-concept studies and a number of early clinical and
pre-clinical programs. PureTech Health’s growing research and
development pipeline has been developed in collaboration with some of
the world’s leading scientific experts, who along with PureTech's
experienced team and a stellar Board identify, analyze and advance very
selectively the opportunities the Company believes hold the most promise
for patients. This experienced and engaged team places PureTech Health
at the forefront of ground-breaking science and technological innovation
and leads the Company between and beyond existing disciplines. For more
information, visit www.puretechhealth.com
or connect with us on Twitter @puretechh.
Forward Looking Statement
This press release contains statements that are or may be forward-looking statements, including statements that relate to the company's future prospects, developments and strategies. The forward-looking statements are based on current expectations and are subject to known and unknown risks and uncertainties that could cause actual results, performance and achievements to differ materially from current expectations, including, but not limited to, those risks and uncertainties described in the risk factors included in the regulatory filings for PureTech Health plc. These forward-looking statements are based on assumptions regarding the present and future business strategies of the company and the environment in which it will operate in the future. Each forward-looking statement speaks only as at the date of this press release. Except as required by law and regulatory requirements, neither the company nor any other party intends to update or revise these forward-looking statements, whether as a result of new information, future events or otherwise.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170524006290/en/
